In this report, we expanded this series of AChE inhibitors based on 1,3-bis[ω-(substituted benzylethylamino)alkyl] uracils in the search for effective AChE inhibitors capable of improving cognitive dysfunctions caused by AD. The gene discussed is ACHE; the disease is Alzheimer disease.